Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemanth R Nelvagal

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2017
Progress toward Fulfilling the Potential of Immunomodulation in Childhood Neurodegeneration?Jonathan D Cooper, Hemanth R Nelvagal
Biochimica Et Biophysica Acta|June 1, 2015
Towards a new understanding of NCL pathogenesisJonathan D Cooper, Marta A Tarczyluk, Hemanth R Nelvagal
Frontiers in Neurology|November 28, 2022
Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinosesJohn R Ostergaard, Hemanth R Nelvagal, Jonathan D Cooper
Frontiers in Neurology|April 21, 2022
Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid LipofuscinosesKeigo Takahashi, Hemanth R Nelvagal, Jenny Lange, et al.
Methods in Cell Biology|February 11, 2015
Quantifying storage material accumulation in tissue sectionsJonathan D Cooper, Helen R E Brooks, Hemanth R Nelvagal
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Immunostaining Methods for Lysosomal Storage Disorder ResearchEwa A Ziółkowska, Sophie H Wang, Hemanth R Nelvagal, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2019
Pathomechanisms in the neuronal ceroid lipofuscinosesHemanth R Nelvagal, Jenny Lange, Keigo Takahashi, et al.
Molecular Genetics and Metabolism|May 19, 2015
Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosisJui-Yun Lu, Hemanth R Nelvagal, Lingling Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Synergistic effects of treating the spinal cord and brain in CLN1 diseaseCharles Shyng, Hemanth R Nelvagal, Joshua T Dearborn, et al.
Human Molecular Genetics|May 17, 2024
Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher diseaseGiulia Massaro, Amy F Geard, Hemanth R Nelvagal, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2017
Progress toward Fulfilling the Potential of Immunomodulation in Childhood Neurodegeneration?Jonathan D Cooper, Hemanth R Nelvagal
Biochimica Et Biophysica Acta|June 1, 2015
Towards a new understanding of NCL pathogenesisJonathan D Cooper, Marta A Tarczyluk, Hemanth R Nelvagal
Frontiers in Neurology|November 28, 2022
Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinosesJohn R Ostergaard, Hemanth R Nelvagal, Jonathan D Cooper
Frontiers in Neurology|April 21, 2022
Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid LipofuscinosesKeigo Takahashi, Hemanth R Nelvagal, Jenny Lange, et al.
Methods in Cell Biology|February 11, 2015
Quantifying storage material accumulation in tissue sectionsJonathan D Cooper, Helen R E Brooks, Hemanth R Nelvagal
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Immunostaining Methods for Lysosomal Storage Disorder ResearchEwa A Ziółkowska, Sophie H Wang, Hemanth R Nelvagal, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2019
Pathomechanisms in the neuronal ceroid lipofuscinosesHemanth R Nelvagal, Jenny Lange, Keigo Takahashi, et al.
Molecular Genetics and Metabolism|May 19, 2015
Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosisJui-Yun Lu, Hemanth R Nelvagal, Lingling Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Synergistic effects of treating the spinal cord and brain in CLN1 diseaseCharles Shyng, Hemanth R Nelvagal, Joshua T Dearborn, et al.
Human Molecular Genetics|May 17, 2024
Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher diseaseGiulia Massaro, Amy F Geard, Hemanth R Nelvagal, et al.
Pageof 3